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Disappearance vs..  
re-emergence
Challenging,
High mortality
Life-threatening
Beyond psychiatry
Offers interface with medicine and neurology
Constantly evolving in understanding 
52 publications in 2006
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Catatonia: Case vintage.
 A 40-yr.old man treated for psychosis with antipsychotic and antimanic
 medications since age of 16, was attending a community clinic, and stabilized
 with lithiumand chlorpromazine therapy.
 Encouraged by stability of condition therapist prescribed olazapine.
 Within a few weeks patient again became psychotic. Perphanizine was prescribed, within 
a day he became febrile, mute and rigid. Hospitalized and diagnosed as NMS, transferred to 
tertiary care facility
 APD was discontinued, further treated with large doses of bromochriptine & dantrolene. 
Repetitive movements prompted diagnosis of epilepsy, so anticonvulsants were administered.
 Lorazepam prescribed in low dose controlled infrequent agitation but he remained mute 
and rigid, required total nursing care
 After few weeks he was unable to stand; hands and legs were in rigid, immobile posture.
 A gastrostomy was done to permit feeding, he developed pulmonary and bladder 
infection requiring antibiotics
 He spent four months in intensive medical care and after that a visiting consultant 
[psychiatrist] recommended lorazepam in high doses.
 When the daily dose was increased to 12mg he responded to commands and smiled at his 
parents, though he remained mute
 ECT was recommended but the hospital had no facility, so he was transferred
 When his mother was signing the consent for ECT she recalled that he had a similar 
episode of rigidity mutism and psychosis at 16 years of age and responded to ECT
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 Lorazepam was reduced to 6 mgs per day and bilateral ECT begun
 After 4 treatments he recognized his parents, vocalized, smiled, was less 
rigid and took oral feedings
 By 9th treatment he was verbally responsive but 4 months of rigidity & 
forced bed rest had left him with limb contractures and such badly impaired 
movements that he was unable to stand or use his hands to feed himself.
 Both catatonia and psychosis were relived
 After 22 ECT he was transferred to rehabilitation center and 4 months later 
he was again able to walk, use his hands and care for himself.
 COMMENTS
 This patient’s ordeal was prolonged by several clinical missteps. Persisting
in a failed trial with bromocriptine and dantrolene was not correct
 Generally if an acutely ill patient has not improved substantially within 7-
10 days of treatment, that treatment needs to be reconsidered and probably changed
 Catatonic features interfering with general medical health, even catatonic 
features attributed to antipsychotic drugs improve substantially within several days 
when properly treated
 For this patient inadequate nursing care allowed contractures to develop 
 The unavailability of ECT at a tertiary care hospital was indefensible.
 A long ill catatonic patient with joint contractures was successfully treated 
with Acts.
 REFERENCE:
 Mashimo et al 1995 quoted in Catatonia by Fink and Taylor 2003 Cambridge
University press; pp 21.
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Catatonia is one clinical condition 
which reminds us that 
patients do not follow books but 
books are written by following patients
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Catatonia: A life threatening 
condition.
 A syndrome
 Catatonia is currently considered to be a 
psychomotor syndrome
 Remarkable constellation of motor and behavioral 
signs and symptoms that often occurs in relation to 
neuromedical insults.
 Structural brain lesions, intrinsic brain disease, and 
other systemic disorders that affect the brain, as well 
as 
 ‘idiopathic’ psychiatric disorders have been found to 
be associated
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Catatonia: Historical evolution
 Catatonia or tension Insanity-
Kahibaum 1874
 Catatonia-dementia praecox 
kraeplin 1899
 Symptoms as manifestation of 
Freudian complexes-Bleuer 1911
 With MDP - kahlbaum 1874
 Motility Psychosis-Wenicke 1900
 Cycloid Motility psychosis- Kleist 
1912 and leonhard 1957
 Catatonic schizophrenia-a group 
of Cerebral System Disorder -
Kleist 1923
 In Childhood & adolescence-
Raecke 1909
 Catatonia & Hysteria-Charcot 
1886
 Catatonia & OCD-Bleuler 
1911,Kruger 2000
It was also well known that it could occur secondary to neurological, 
toxic-metabolic and infectious etiologies.
Identified exclusively with schizophrenia as late as DSM III/ III-R
This limitation changed in DSM-IV.
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Epidemiology ( definition & concept)
1.rates of catatonia- a) General psychiatric Condition-7-175 
hospitalized acute psychosis  b) mood disorder- 13-31% 
c) schizophrenia- 6% in 1850 & 0.5% in 1950
incidence of catatonia
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Nosology 
 Motility psychosis
 Catatonic schizophrenias
 A- unsystemetic catatonic, 
schiz, periodic catatonia
 B-systematic- schizophrenias
 1.Para kinetic
 2.mannerist
 Pros kinetic
 Negativistic
 Speech prompt
 Speech inactive
 Nosologic validity continues to 
be debated
 Concept & descriptive 
psychopathology-still 
insufficient
 Study of catatonia can be 
advanced by--
 Adopt the approach of 
‘catatonia across psychiatric 
illness’
 Reject notion of subtype or 
modifier
 Postulate as ‘ separate entity’
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Current phenomenological 
classification 
As per DSM-IV; Now it is categorized as 
 Catatonic disorder due to general medical condition
 Mood disorder with catatonic features
 The catatonic type of schizophrenia.
Historically , Pre and post neuroleptic era has been found 
strongly associated with incidence of catatonia.
 Psychogenic catatonia
 Neuroleptic induced catatonia -NMS
 [ catatonia preceding NL administration and developing into 
NMS]
 Are possibly most suitable clinical classification.
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 Catatonia is a condition qualifying for finding its own place in various 
diagnostic systems. Because:-
 Catatonia is common
 Is Identified  as a syndrome
 Can be Delineation from other syndromes[ differential diagnosis]
 Catatonia is also known by by other names
 Known to have Good response to specific treatment
Catatonia in psychiatric 
classification: the evidence
Common causes of catatonia
 Mood disorder
 General medical and neurological conditions
 Non-affective psychosis
 Genetic form of catatonia
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Proposed category for 
classification
 DSM Code xxx.0
 Catatonia
 Code.xxx.1 Nonmalignant catatonia
 Code.xxx.2 delirious catatonia
 Code.xxx.3 malignant catatonia,NMS, serotonin syndrome
 Specifier
 Code.xxx.x1 secondary to mood disorder
 Code.xxx.x2 secondary to gen.med.condition
 Code.xxx.x3 secondary to  neurological dis.
 Code.xxx.x4 secondary to psychiatric disorder
Max Fink & Taylor; 2003 
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Proposed diagnostic criteria
 A.immobility,Mutism,or stupor of at least 1 hours 
duration,associated with at least one of the 
followings: catalepsy,autonomic obedience,or 
posturing,observed or elicited,on two or more 
occasions.
 B.in absence of immobility,Mutism or stupor,at least 
two of the 
followings:stereotypy,echophenomena,catalepsy,aut
onomic 
obedience,posturing,negativism,gagenthalten, 
ambitendency
Max Fink & Taylor; 2003 
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Share a common pathophysiology,& clinical 
manifestation
While most cases of catatonia do not meet 
criteria for NMS , all unequivocal cases of NMS 
appear to meet criteria for catatonia.
Though the syndrome has been described in different 
times , there is remarkable amount of similarity
Catatonia & NMS {NL induced catatonia},
a lethal and malignant syndrome
with high mortality-NMS : first description 1960 
by Delay et al.
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Mutism           Posturing 
Immobility      Negativism 
Staring           Withdrawal 
The classical features of catatonia: 
about 42 symptoms have been identified
Catatonia has three groups of symptoms:
• motor symptoms
• behavioral symptoms
• emotional symptoms 
All three have different underlying 
pathophysiological mechanism
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Subtypes and classification: 
Main subgroups are:
Malignant and Non-malignant Catatonia
Catatonic withdrawal
Catatonic excitement
Alternating
Periodic [ excitement 
alternating with 
stuperous state]
Lethal catatonia
Catatonic stupor
Malignant 
Simple - non-
malignant
Pernicious
NMS
variants
 Clinical description, course and outcome
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Catatonia :
Idiopathic: without brain atrophy & -with brain atrophy
Associated with bipolar disorder;   major depression  other 
affective disorder:  schizophrenia;  other psychiatric disorder 
[Psychogenic]
Parkinson's 
Toxic encephalopathy
Metabolic encephalopathy
Other medical disorders
NMS
Neuroleptics
Other prescribed psychotropics
Illicit psychotropics
TLE
other Seizure Disorder
brain tumor
brain trauma
encephalitis- post encephalitis 
state
cerebro vascular diseases
focal brain lesions
akinetic mutism
Catatonia secondary to:( Medical Catatonia)
Phencyclidine exposure, SLE, Corticosteroids; disulfiram Porphyria
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Assessment of catatonia
by Braunig catatonia rating scale
The scale contains 21 items 
(16-motor symptoms & 5 behavioral symptoms rated from 0-4)
Motor excitement
Verbigeration
Stereotypis
Motor inhibition
Iteration 
Grouping
Impulsivity
Mutisim
Grimacing
Exaggerated 
responsiveness
blinking
Mannerism
Gerky movements
Genhalten
Rigidity
Negativism
Parakinesis
Postural
Waxy flexibility
Rituals
Automatic obedience
Mood disorder vs. schizophrenia
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Catatonic spectrum disorders:
depending upon shared  neurobiology
 Lethal malignant catatonia - high mortality
 NL induced catatonia, NMS,
 Serotonin syndrome
 Classical catatonic stuperous state
 Various independent catatonic symptoms
 Catatonia variants
 Non-malignant simple catatonia
 Autism spectrum disorder
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Incidence of catatonic schizophrenia in 
various countries 
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has reduced over time due to several 
factors , generally observed in about 
10-15% of psychiatric population;4% 
TO 10% IN ACADEMIC INPATIENT 
UNITS
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 Huber 1979 4.7
M.Bleuer 1972 33.6
Muller 1976 21.5
Warthen 1967 7.5
Morrison 1973 10
Kasper 1975 5
Strass 1981 5.7
Kane 1988 2
Stieglitz 1992 8
Are we witnessing the disappearance of catatonic 
schizophrenia?  Symptoms or syndrome.??
 E.Bleuer 1991 >33
 Kraepelin     1913 19.5
 Mayor-Gross 1932  30
Leonhard 1938-68  35.4
Leonhard 1969-86  30
Astrup 1962 25.6
fish 1964 30.5
Huber 1957 27
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Catatonia in depression
feature motoric immobility
stupor;extreme agitation;extreme 
negativism;posturing;stereotyped 
movements,mannerisms,or grimacing and echolalia 
or echopraxia
treatment BZ with continued oral administration,
When , no relief, urgent provision for ECT
After catatonic symptoms are relieved Tx should 
continue with ADD,Lithium, APD or combination
outcome Efficacy of ECT usually appears after few 
treatments, ECT may initially be administered 
daily
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Catatonia in mania
features develop in 1/3 of patients.
are--motor excitement,Mutism,and stereotypic 
movements,patients exhibiting stupor may go on to show more 
typical signs of mania,
greater episode severity,mixed states,and poorer short-term 
outcome,
treatment Lorazepam is effective,
ECT is most effective ,regardless of etiology,should be 
considered if BZ fails.
outcome NL generally have exhibited poor efficacy,
Leonhard: 2 types of MDP with catatonic 
features;with or without catatonia;significantly 
differing on me n number of days in hospital
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High risk or At-risk or Vulnerable for 
catatonia & poor prognosis
 Male gender
 Adolescent onset
 Presence of autistic traits
 Obstetric events
 Post-natal brain insult
 Soft neurological signs
 NL sensitivity
 Family history of catatonia
 Catatonia generally has good outcome but presence 
of catatonic symptom has poor prognosis of 
schizophrenia or mania
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NMS & its Risk factors  
 Mortality has decreased from 20% to 10% and incidence has also 
decreased.
 Life time incidence - about 0.2% amongst antipsychotic users
 Hyperthermia and rabdomyolysis may lead to renal failure
 CPK rises dramatically [ even  up to 60K units]
 Risk factors include:-
 Rapid dose escalation of HP , first generation APD
 Parenteral administration of APD
 Underlying neurological impairment
 NMS is probably less common with second generation APD  than 
with first one.
 Incidence with first generation is low now possibly because of low 
dosage than in the past.
 Polypharmacy, concomitant anticholinergics,Lithium
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NMS & its Risk factors 
 May be fatal, if untreated,
 Tx. Includes : temperature control by cooling,fluid 
correction,DA agonist-Bromcriptine 2.5 mg QDS, muscle 
relaxant, dantrolene 1-2.5 mg/kg,IV 6 hourly
 ECT is indicated if catatonia related to NMS persists or 
response is inadequate with drugs,
 Need for APD should be carefully assessed, before 
resumption,
 When another trial of APD is attempted, second generation , 
particularly clozapine are preferred,
 A re-challenge should begin with low dose and slow titration
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NMS
variables
Death
N=17
Sequelae
N=10
Full recovery
N=22
age 50.3 51.3 43.1
female 59% 60% 23%
Psychomotor excitement 41% 60% 36%
dehydration 54% 80% 64%
Lithium 18% 30% 9%
Antiparkinsons 76% 30% 77%
I/M NL 35% 30% 14%
Dose NL/day 789 486 728
Loading dose NL/d2 121 51 127
dantrolene 59% 80% 59%
bromcriptine 14% 30% 41%
Max CPK 1000 IU/L 13.9 25.5 49.2
Max body temperature 39.4 40 38.6
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Differential Diagnosis
organic,psychogenic,drug induced, idiopathic,
--------------------------------------------
Idiopathic primary catatonia
Secondary catatonia
Lethal catatonia
Catatonic excitement
•Diagnosis is essentially clinical supported by 
•measurement and rating scales,
•Rule out  other causes 
•presents as emergency ,
•move very quickly and systematically
•Often diagnosing catatonia in schizophrenia vs. mania is difficult at 
the beginning.
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Clinical dilemmas and challenges
 Very severe cases has less problem,
 Most of the difficulties arise in borderline cases.
 New contact : most would adopt ‘rule out’ .
 Time length for definitive Tx is crucial 
 Severe excitement is a management problem
 Partial syndromes only
 When diagnostic criteria is not fulfilled
 Presence of high fever and h/o NL
 Rapid cycling and periodic catatonia
 When response does not progressed
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Clinical dilemmas and challenges
 When response does not sustain
 Frequent relapses 
 Determining psychiatric diagnosis schizophrenia vs. mood 
disorder
 Presence of psychosis; 
 Use Antipsychotic ; to be or not to be
 Should CSF be checked / routinely 
 Deciding about ECT in medically compromised
 Therapeutic or service set up
 Issues of transfer 
 Issues around consent and capacity
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 Late onset, paediatric, in pregnancy 
 Planning relapse prevention
 Which antipsychotic in catatonic Schizophrenia after 
termination with ECT and which MS and ADD in Bipolar 
Disorder?
 Virtually all APD typical or atypical have been known to cause 
NMS,Incipient NMS or its variants, including clozapine.
 All atypical APD have shown some degree  of response in 
NMS and catatonia? 
 Clinical guidelines are not clear and experience is the best 
guide.
Clinical dilemmas and challenges
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APA practice Guidelines 2006.
 “there are at present no  treatment strategies 
specific to the various subtypes [ of schizophrenia] 
with exception to the use of BZ for Catatonia”
 In Mania use BZ and ECT
 In depression; ‘concurrent ADD use’ and BZ with 
ECT, “after catatonic features are relieved TX may 
be continued with ADD,Lithium,APD or a 
combination..”
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Special conditions
 Catatonia-autism  spectrum
 Catatonia in childhood and adolescence
 Late-onset catatonia
 Catatonia in liver transplant
 Post-partum catatonia
 Catatonia in co-morbid medical condition like 
hypertension
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Clinical advances
 Catatonia is an infrequent but severe condition in young people, and 
is usually associated with schizophrenia. 
 Obstetric complications and neurological abnormalities in 
neuroleptic-naive psychotic patients.
 Blueprints for the assessment, treatment, and future study of 
catatonia in autism spectrum disorders.
 Shared susceptibility region on chromosome 15 between autism and 
catatonia.
 Classification matters for catatonia and autism in children.
 NMS in adolescents after brief exposure to olanzapine
 Catatonia in Alzheimer's Lewy body dementia after Donapezil
 Malignant and late onset catatonia
 Catatonia after single dose of ‘ecstasy
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Catatonic patients are well able to
initiate movements, but they are apparently 
unable to terminate the movement
once initiated in an appropriate way. 
In contrast to initiation, neural network  study of 
underlying termination of movement has been 
neglected in the research to date.
Fundamental Problem
A disorder of Motivation and Movement link
15th, January 2007 Amresh Srivastava , asrivas9@uwo.ca 37
All information put together, it appears 
that the 
 Motor symptoms  ----- nigrostriatal, basal ganglia and motor 
cortex
 Emotional symptoms ---- prefrontal and limbic cortex
 Behavioral symptoms---mesolimbic cortex
 All three are interdependent because of ‘circuits and loops 
which are closed within these structures.
 That there is a pre-existing  brain insult present in vulnerable 
candidates
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Various hypothesis have been proposed.
 Neurotransmitter hypothesis
 Universal field hypothesis
 Vulnerability theory because of brain structural changes
 Emotional-motor activation paradigm
 Motivation-movement paradigm
 Neurochemical: increased CPK and Low serum Iron
 Neuronal Circuits paradigm
 Restitutive dopamine hypothesis
 Top-down modulation”: A Neuropsychiatric hypothesis: parallel from 
Parkinson's disease
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Dopamine hypo-activity
 There is dysfunction in neurotransmission in cortical and sub-
cortical areas.
 The dysfunction is a result of a combination of NT 
involvement.
 Leading NT involved are DA,GABA,5HT,NMDA
 There is hypofunction D2 activity in various cortical areas 
mesolimbic, nigrostriatal, motor, prefrontal and orbitofrontal 
areas
 Decreased D2 function is also found in caudate nucleus, 
nucleus accembens, palladium and thalamus.
This hypothesis proposes that it is the interaction of 
these systems that predisposes , initiates, and 
maintains the twin synd ome  of c tatonia & NMS 
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Catatonia is a delicate balance between 
dopamine and Gaba neurons
NMDA
Major NT  
DA,
GABA,
NMDA,
5HT2a
Gaba-A
Gab -B--ratio decreased
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Gaba and major brain areas
 The ratio of GABA A and GABA B may play a role in 
development of catatonia. There is Hypo activity at 
GABA A receptor; Lorazepam, a GABA agonist is 
effective in catatonia
Serotonin Hyperactivity at the 5-HT 1A receptor
hypo activity at 5HT 2A receptor
Glutamate Hypo function of NMDA Receptor
 Major Brain regions implicated in catatonia are:
 Limbic system - nucleus accumbens
 Thalamus          Caudate nucleus  Motor area
 Fronto-orbito cortex Right posterior parietal cortex        
Mesolimbic and mesostriatal cortex,
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DA GABA
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catatonia Findings of brain imaging
Structural 
changes 
Neuropathological 
findings 
Caudate Nucleus:Palladium; nucleus 
accembens;Thalamus shows Decreased cell 
density
Functional 
changes
reduced  activity in medial orbitofrontal cortex during 
negative emotional stimulation,suggesting possible 
initiation point.
imaging and neuropsychology indicate a 
relationship between deficits in visual-constructive 
function & decreased rCBF in the right posterior 
parietal cortex, alteration in right posterior parietal 
function may count for the deficit in termination of 
movements responsible for motor symptoms of 
posturing.
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Negative emotional 
processing in the right medial 
orbitofrontal cortex may be 
particularly altered in catatonia 
with an abnormal functional 
connectivity to the 
premotor/motor cortex
In healthy individuals 
termination of movement 
involves ….
the right posterior parietal 
cortex because the 
registration.
on line monitoring of the 
respective spatial position of 
the movement may be of 
central importance for an 
appropriate termination.  
Movement control
15th, January 2007 Amresh Srivastava , asrivas9@uwo.ca 45
Neuronal circuits and catatonia
 Each circuit has  cortico/limbic, striatal, pallidial/nigral, 
and thalamic nodal points with the loops closed by 
thalmocortical connections.
 Any neuromedical or psychiatric disturbance significant 
enough to disrupt the GABA-DA balance in the 
mesotriatal-mesocortocolimbic medial forebrain bundle 
of DA tracts 
 with terminal fields in nucleus accumbens, the anterior 
cingualte , and the prefrontal cortex system anywhere 
along the circuitry will potentially set off a catatonic 
response.
Cognitive,behavioral and emotional circuits
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Dopamine restiturive hypothesis
 DAgic system in involved in protecting against the emergence of psychotic 
symptoms,
 DA-gic system then may stabilize mental homeostatic by spontaneous 
Down regulation of its own function
 In some patients, this down reg. is sufficient to maintain a non-psychotic 
state
 if the biological or psychological stresses are so severe that down regulation 
is not adequate to prevent psychosis.
 The syndrome appears
 Periodic catatonia: confirmation of linkage to chromosome 15 and 
further
evidence for genetic heterogeneity.
Periodic catatonia is the first sub-phenotype of schizophrenic 
psychoses with confirmed linkage despite the
existence of considerable genetic heterogeneity.
15th, January 2007 Amresh Srivastava , asrivas9@uwo.ca 48
“Top-down modulation”: A
Neuropsychiatric hypothesis
 Differential diagnosis of motor symptoms is difficult.
 Symptoms may have CNS origin [Parkinson's] or psychiatric [ catatonia]
 Despite differences in origin symptoms may appear similar
 Possibility of dissociation between origin and clinical appearance may reflect 
functional brain organization in general & cortical-cortical/subcortical in particular.
 hypothesized : similarities and differences between Parkinson's disease and 
catatonia - accounted for by distinct kind of modulation between cortico-cortical 
and cortico-subcortical relation.
The different symptoms be accounted for by dysfunction in orbitofrontal-
prefrontal/parietal cortical connectivity reflecting “ horizontal modulation” of 
cortical-cortical relation.
 reflecting “vertical modulation” of caudate and other BG by GABA-
ergic mediated orbitofrontal cortical deficit may account for motor 
symptoms in catatonia.
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Issues about management
 Over time the mortality has decreased
 Needs emergency and multidisciplinary care
 Often requires Intensive care team
 Management focus has to be on 1. Establishing the diagnosis 
asap.2. Arrange supportive treatment,3.rule out secondary 
causes.4consider definitive treatment,all without loss of time
 Clinical presentation is rarely ‘uncomplicated’
 Duration of untreated illness is very high.
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Management 
 Thus complications of nutritional deficiency,starvations, 
posturing, metabolic imbalance,infection,worm infestation,skin 
diseases,injury, cardiac complication,fever and toxemia are 
common.
 Thus management should address:-
 Vital functions, nutrition, hydration, correction of 
electrolyte,infection and other relevant condition, and
 Then proceed for definitive treatment with BZ,ECT etc.
 Fitness to anaesthesia and ECT is a crucial clinical issue.
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Treatment options 
 LORAZEPAM IV CHALLENGE
 IF POSITIVE, LORAZEPAM ORAL
. DOSAGES ARE HIGH- 4-12 MG/DAY
 ECT
DAILY TREATMENT FOR 2-5 DAYS
BILATERAL ELECTRODE PLACEMENT
 AVOID ANTIPSYCHOTIC DRUGS
Electroconvulsive therapy and lately benzodiazepines are 
not only effective treatment options in this form of  
catatonia,but also helped generate neurobiological 
hypotheses concerning its pathophysiology
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Treatment of catatonia with IV lorazepam
Prospective Study : Bush et at., 1996 
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Ungvari : demonstrated that lorazepam was not effective in chronic states of 
catatonia, associated with chronic psychiatric conditions.----
suggesting that not all catatonia are lor zep m - responsive
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Treatment of Catatonia
 A. simple 
catatonia(including NL-
induced catatonia)
 Lorazepam
 Still catatonic
 DA Agonist
 Still catatonic
 ECT
 B.lethal catatonia 
(including NMS)
 Lorazepam
 And/or
 DA agonist +/-
Dantrolene
 Still catatonic
 ECT - prior to 5 days
Valproate for catatonia: need for caution in 
patients on SSRIs and antipsychotic.
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Advances in management
 meantime, may be beneficial in catatonic schizophrenia due to a 
glutamatergic dysfunction present in catatonic patients.
 Clozapine monotherapy for catatonic schizophrenia: should 
clozapine be the treatment of choice, with catatonia rather than 
psychosis as the main therapeutic index?
 Clozapine withdrawal catatonia associated with cholinergic and 
serotonergic rebound hyperactivity: a case report.
 Medical complications of catatonia: a case of catatonia-induced 
deep venous thrombosis.
 Gilles de la Tourette form of catatonia: response to ECT.
 Catatonia and transcranial magnetic stimulation.
 Lethal catatonia responding to high-dose olanzapine therapy.
 Lithium carbonate in prophylaxis of reappearing catatonic stupor: 
case report.
 Treatment of catatonic syndrome with fluoxetine. Case report]
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Advances: future questions 
 Nonconscious processing, anterior cingulate and catatonia
 Catatonia is not ready for ‘unified theory’
 Does catatonia has a specific brain biology
 What medical catatonia tell us about top down modulation
 Catatonia- a window into the cerebral underpinnings of will
 Catatonia-a disorder of motivation and movement
 Cognitive-motor deficit in catatonia
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1.our conceptualization of catatonia has changed 
over years– away from a motor manifestation of 
schizophrenia and towards a motor,behavioural, 
emotional manifestation of mixed mania and many 
other organic disorders
-----------------------------------------------------------
2.  its patho-physiology continues to be a mystery.
3. however it is an important clinical syndrome 
and still continues to be life threatening condition in 
neuropsychiatry
Finally , its clear that 
